Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 1,570,000 shares, a growth of 72.6% from the May 31st total of 909,800 shares. Approximately 8.0% of the shares of the company are sold short. Based on […]